瑞替普酶溶栓治疗急性心肌梗死100例效果观察

目的分析瑞替普酶溶栓治疗急性心肌梗死患者的临床疗效。方法选取我院收治的100例ST段抬高性急性心肌梗死患者作为研究对象，观察组52例患者采用瑞替普酶溶栓治疗，对照组48例患者采用尿激酶进行治疗，两组患者其他治疗相同，对比分析两组临床疗效。结果治疗后，观察组总有效率优于对照组，血管再通率高于对照组，血管开通时间短于对照组患者，差异均有统计学意义(P<0.05)。结论瑞替普酶溶栓治疗急性心肌梗死具有血管开通率高、时间短、出血程度轻等优点，值得临床推荐。

Clinical efficacy of ReteDlase thrombolylic theraDy for 100 Datientz with acute myocardial irffarction

Objective To investigate the clinical efficacy of thrombolysis in the treatment of 100 patients with acute myocardial infarction. Methods 100 patients with ST-segment elevation acute myocardial infarction were divided into two groups, including the observation group of 52 cases treated with reteplase thrombolytic therapy and the control group of 48 patients with urokinase for treatment, and the clinical efficacy of the two groups were compared. Results After treatment, the total efficiency of observation group was significantly higher than the control group, recanalization rate of the observation group patients was significantly higher in patients with vascular opened the time is significantly shorter than the control group patients, the differences were statistically significant（P〈0.05）. Conclusion Reteplase thrombolysis therapy in patients with acute myocardial infarction has good efficacy with short time and mild Needing, and it is worthy of clinical widely promoted and applied.